BioSpace News Archive

Role of Biomarker in Cancer Antibodies Immunotherapy Development

The breakthrough in cancer therapy was witness by the introduction of immunotherapeutic approaches.

April 1, 2022
·
4 min read
Biotech Beach

Mycrodose Therapeutics Announces First Clinical Candidate for Ketamine-Based Drug Delivery Device for Oral Mucositis

Oral mucositis is a painful and potentially treatment-limiting disorder often associated with radiation therapy and chemotherapy of the head, neck and throat cancers, yet mucositis also impacts a large percentage of patients being treated for other cancers.

April 1, 2022
·
4 min read
Pharmadrug Advances PD-001, Its Patented, Improved Version of Cepharanthine for Oncology and Infectious Disease

Work completed thus far on the parent molecule, cepharanthine by PharmaDrug and others, potentially de-risks and expedites several aspects of these studies.

April 1, 2022
·
18 min read
Biotech Bay

Tricida to Present at the Needham Virtual Healthcare Conference - Apr 01, 2022

Tricida, Inc. announced that it will present at the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11, 2022 at 10:30 am Pacific Time / 1:30 pm Eastern Time.

April 1, 2022
·
1 min read
Business

BioStem Technologies Inc. Reports December 31, 2021 Year End Financial Results

BioStem Technologies Inc. today reported financial results for the year ended December 31, 2021.

April 1, 2022
·
10 min read
BioMidwest

UCB Showcases Strength of Broad Neurology Portfolio at 74th American Academy of Neurology (AAN) Annual Meeting

UCB announced that new data from its expansive and innovative neurology portfolio will be presented at the 74th American Academy of Neurology Annual Meeting, from April 2-7, 2022.

April 1, 2022
·
42 min read
Biotech Bay

Scribe Therapeutics to Participate in Upcoming Goldman Sachs The New Guard: Privates Leading the Disruption in Healthcare Investor Conference

Scribe Therapeutics Inc. today announced its participation in the Goldman Sachs The New Guard: Privates Leading The Disruption In Healthcare conference.

April 1, 2022
·
1 min read
Business

Blue Cross and Blue Shield of Minnesota Reports 2021 Financial Results

The Blue Cross and Blue Shield of Minnesota (Blue Cross) family of companies today announced audited financial results for 2021.

April 1, 2022
·
5 min read
Business

Todos Medical Reports Fourth-Quarter and Full-Year 2021 Financial Results and Corporate Updates

Todos Medical, Ltd. today reported financial results for the fourth quarter and full-year ended December 31, 2021 and provided corporate updates.

April 1, 2022
·
15 min read
Drug Development

Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting

Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces new data from the pivotal Phase II/III trial of leniolisib for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome.

April 1, 2022
·
8 min read